Related Experiment Video
Updated: Jul 15, 2026
10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Genetic variability in inflammation pathways and prostate cancer risk
Jielin Sun1, Aubrey Turner, Jianfeng Xu
1Center for Human Genomics, Wake Forest University, Winston-Salem, NC 27157, USA.
Urologic Oncology
|May 8, 2007
Summary
Genetic susceptibility to prostate cancer is linked to chronic inflammation. Key genes involved in inflammation, like RNASEL and MSR1, are associated with increased prostate cancer risk.
Area of Science:
- Oncology
- Genetics
- Immunology
Background:
- Prostate cancer susceptibility has a genetic component.
- Chronic inflammation in prostate tissues is increasingly implicated in prostate cancer development.
- Genes within inflammatory pathways are associated with prostate cancer risk.
Purpose of the Study:
- To review key genetic findings related to prostate cancer risk.
- To highlight genes identified through family and case-control studies.
- To discuss the role of gene-gene interactions in prostate cancer.
Main Methods:
- Review of genetic findings from family and case-control studies.
- Identification of genes associated with inflammatory pathways and prostate cancer risk.
- Synthesis of current evidence on genetic susceptibility and inflammation.
Main Results:
- Genes such as ribonuclease L (RNASEL) and macrophage scavenger receptor 1 (MSR1) were identified through family studies.
- Case-control studies implicated genes including macrophage inhibitory cytokine-1 (MIC-1), interleukins (IL-8, IL-10), vascular endothelial growth factor (VEGF), intercellular adhesion molecule (ICAM), and Toll-like receptors (TLR-4, TLR-1-6-10 gene cluster).
- Evidence suggests multiple genes interact to increase prostate cancer risk.
Conclusions:
- Prostate cancer risk is influenced by a complex interplay of multiple genes involved in inflammation.
- Future research should focus on gene-gene interactions to better understand prostate cancer development.
- Advances in high-throughput genotyping and data analysis are crucial for future studies.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...